Adherium Limited (ASX:ADR)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
Sep 4, 2026, 9:59 AM AEST
Adherium Revenue
In the fiscal year ending June 30, 2026, Adherium had annual revenue of 2.10M AUD with 157.02% growth. Adherium had revenue of 801.40K in the half year ending December 31, 2025, with 112.47% growth.
Revenue
2.10M
Revenue Growth
+157.02%
P/S Ratio
261.31
Revenue / Employee
52.51K
Employees
40
Market Cap
548.87M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 2.10M | 1.28M | 157.02% |
| Jun 30, 2025 | 817.24K | -23.75K | -2.82% |
| Jun 30, 2024 | 840.98K | -2.35M | -73.68% |
| Jun 30, 2023 | 3.20M | 2.67M | 504.07% |
| Jun 30, 2022 | 529.00K | 128.00K | 31.92% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 34.87M |
| CleanSpace Holdings | 19.82M |
| Micro-X | 15.09M |
| ImpediMed | 14.61M |
| CurveBeam AI | 8.67M |
| CONNEQT Health | 7.96M |
| Atomo Diagnostics | 5.33M |
| OncoSil Medical | 5.09M |
Adherium News
- 2 days ago - Earnings Estimates Moving Higher for Abn Amro BK N V - Unsponsored ADR (AAVMY): Time to Buy? - Nasdaq
- 2 days ago - All You Need to Know About Leonardo S.P.A. - Unsponsored ADR (FINMY) Rating Upgrade to Buy - Nasdaq
- 3 days ago - All You Need to Know About Pony AI Inc. - Sponsored ADR (PONY) Rating Upgrade to Buy - Nasdaq
- 6 days ago - Govt moves to replace colonial-era court fee law - The Times of India
- 6 days ago - Here's What Could Help Yokohama Financial Group, Inc. - Unsponsored ADR (CRDIY) Maintain Its Recent Price Strength - Nasdaq
- 9 days ago - Here's Why ASICS Corporation Unsponsored ADR (ASCCY) Looks Ripe for Bottom Fishing - Nasdaq
- 10 days ago - BeOne Medicines Ltd. - Sponsored ADR (ONC) is a Great Momentum Stock: Should You Buy? - Nasdaq
- 10 days ago - What Makes Mitsui O.S.K. Lines Ltd. - Unsponsored ADR (MSLOY) a Good Fit for 'Trend Investing' - Nasdaq